secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001493152-26-012683
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies announces virtual physician roundtable on CyPath® Lung for April 8, 2026
--------------------------------------------------------------------------------

- Webinar titled 'CyPath® Lung in Practice: A Physician Roundtable Discussion' on April 8, 2026 at 7 p.m. ET.
- Moderated by CMO Gordon H. Downie, MD, PhD; panel includes three pulmonologists sharing real-world cases.
- CyPath® Lung achieved 92% sensitivity, 87% specificity, 88% accuracy in detecting lung cancer in high-risk patients with small nodules.
- First of a series aimed at integrating noninvasive CyPath® Lung into pulmonary practice for nodule management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226012683/0001493152-26-012683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226012683/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer